CrunchBase is hiring! Check out our open positions →
Register | Login or

General Information

Websitefusionip.co.uk
Phone0114-275-5555
Employees

Funds

Offices

Sheffield, GBR
The Bioincubator
40 Leavygreave Road
Sheffield, S3 7RD, GBR

Tags

Fusion IP

Fusion IP owns the rights to 100% of university-owned research generated at two of the UK’s leading universities – The University of Sheffield and Cardiff University. These exclusive partnerships enable us to develop some of the world’s most advanced and exciting science, in fields as varied as clean energy, electronics, engineering and medicine; turning world class research into valuable businesses through the creation of portfolio of companies.

Milestones

Investments

Company Date Round Size Participants
Diurnal 3/12Venture Round£335k1
Seren Photonics 3/12Venture Round£1.8M3
MedaPhor 5/10Venture Round£325k2
Mesuro 5/10Venture Round£350k3
Diurnal 12/09Debt£600k1
Phase Focus 2/08Venture Round$1.18M2
Abcellute 9/07Venture Round£400k2
Asterion 5/06Venture Round$678k2
CellTran 8/05Venture Round$4.82M4

Videos

Sources

  1. Diurnal Raises £335K in Funding (finsmes.com) [edit]
  2. Seren Photonics, raises £1.8m to accelerate commercialisation of its revolutionary LED technology (4-traders.com) [edit]
  3. MedaPhor raises £325k to commence sales of its new ScanTrainer simulator (medaphor.com) [edit]
  4. UK, Mesuro Receives £350,000 in Funding after Completing Milestones (finsmes.com) [edit]
  5. Diurnal Receives £600,000 Investment from Fusion IP and Finance Wales (finsmes.com) [edit]
  6. £600,000 Investment into Imaging Company Phase Focus (phasefocus.com) [edit]
  7. Biofusion signs MOU with Finance Wales and increases stake in Abcellute (fusionip.co.uk) [edit]
  8. Cap Funding Report [edit]
  9. Cap Funding Report [edit]
Edit This Page
Last Edited 3/19/12

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy